Keywords: Pharmaceutical Industry


Novo Nordisk seeks US court order to block Eli Lilly weight-loss drug advertising

Novo Nordisk has intensified its legal battle with rival Eli Lilly by seeking a preliminary injunction in a U.S. court to halt advertisements promoting Lilly's obesity and diabetes medicines. The move marks the latest escalation in the fierce competition between the two pharmaceutical giants for......

Bayer secures €3 billion from Apollo in contraceptives business investment deal

German pharmaceutical and life sciences group Bayer has secured €3 billion ($3.4 billion) in equity financing through an agreement with funds managed by Apollo Global Management, strengthening its capital structure while retaining control of one of its key healthcare businesses. Announced on Friday,......

Sun Pharma expands portfolio with Innovcare Lifesciences acquisition

Sun Pharmaceutical Industries, one of India's leading pharmaceutical companies, has announced an agreement to acquire Innovcare Lifesciences in a transaction valued at approximately 2.71 billion Indian rupees, equivalent to nearly $28.7 million. The acquisition will give Sun Pharma full ownership......

Laprophan expands European footprint with completion of Rivopharm acquisition

Morocco-based pharmaceutical group Laprophan has completed the acquisition of Swiss company Rivopharm, marking a significant milestone in its international expansion strategy and strengthening its presence in the European pharmaceutical market. Rivopharm is a specialist pharmaceutical company focused......

Roche maintains German investment despite industry pullbacks

Swiss pharmaceutical and diagnostics group Roche has confirmed that it will proceed with its planned investment in Germany, even as some competitors scale back spending in response to changes in national healthcare policy. The company said it will continue investing approximately €600 million in......

Fulcrum Therapeutics shares plunge after halting sickle-cell drug over FDA safety concerns

Shares of Fulcrum Therapeutics fell sharply by 50% in premarket trading after the company announced it was discontinuing development of its experimental sickle-cell disease treatment due to safety concerns raised by the U.S. Food and Drug Administration (FDA). The decision centers on the oral drug pociredir,......

US Supreme Court rejects Eli Lilly challenge to Whistleblower Law

The Supreme Court of the United States has refused to hear a legal challenge brought by Eli Lilly and Company against a historic whistleblower law that allows private citizens to file fraud lawsuits on behalf of the federal government. The decision leaves in place a lower court ruling ordering the pharmaceutical......

Morocco overhauls pharmaceutical law to strengthen health sovereignty

Morocco has launched a major reform of its pharmaceutical regulatory framework through a new legislative proposal aimed at modernizing the country’s drug and pharmacy code. The draft law was presented on 14 May 2026 before the Social Sectors Committee in the national parliament. It seeks to strengthen......

Eli Lilly expands investment with $4.5 billion boost to Indiana manufacturing sites

Eli Lilly and Company has announced a new $4.5 billion investment in its manufacturing operations in the state of Indiana, reinforcing its long-term commitment to expanding production capacity in the United States. Major expansion in Indiana The additional funding will be allocated across two of the......